FIELD: medicine, organic chemistry.
SUBSTANCE: the present innovation deals with new benzothiazole derivatives and medicinal preparation containing these derivatives for treating diseases mediated by adenosine receptor A2.A.. The present innovation provides efficient treatment of the above-mentioned diseases.
EFFECT: higher efficiency of therapy.
14 cl, 354 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BENZOTHIAZOLES | 2002 |
|
RU2293736C2 |
| BENZOTHIAZOL DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS | 2004 |
|
RU2351597C2 |
| DERIVATIVES OF NICOTINE- OR ISONICOTINE-BENZOTHIAZOLE AND MEDICINAL AGENT | 2002 |
|
RU2294933C2 |
| DERIVATIVES OF BENZOTHIAZOLE AS ADENOSINE RECEPTOR LIGANDS AND MEDICINAL AGENT | 2002 |
|
RU2295523C2 |
| BENZOTHIAZOLE DERIVATIVES AND THEIR APPLICATION IN TREATMENT OF DISEASES RELATED TO ADENOSINE A RECEPTORS | 2004 |
|
RU2348622C2 |
| 2-AMINOBENZOTHIAZOLYLUREAS AS ADENOSINE MODULATORS | 2002 |
|
RU2311905C2 |
| DERIVATIVES OF BENZOTHIAZOLE AND MEDICINAL AGENT BASED ON THEREOF | 2002 |
|
RU2301232C2 |
| DERIVATIVES OF BENZOTHIAZOLE AND MEDICAMENT BASED ON THEREOF | 2002 |
|
RU2293083C2 |
| BENZOTHIOPHENES AS MODULATORS OF ADENOSINE RECEPTORS | 2002 |
|
RU2299882C2 |
| BENZOTHIAZOLE DERIVATIVES | 2005 |
|
RU2382782C2 |
